Use of an in vivo system to determine the G418 resistance phenotype of bloodstream-form Trypanosoma brucei brucei transfectants

We determined the level of susceptibility of Trypanosoma brucei brucei to the aminoglycoside G418 in vivo and demonstrated that it is possible to select for G418-resistant transfected T. brucei brucei bloodstream parasites in a mouse host by inoculating the drug intraperitoneally at doses between 40...

Full description

Bibliographic Details
Main Authors: Murphy, N.B., Muthiani, M., Peregrine, A.S.
Format: Journal Article
Language:Inglés
Published: American Society for Microbiology 1993
Subjects:
Online Access:https://hdl.handle.net/10568/30080
_version_ 1855519048823996416
author Murphy, N.B.
Muthiani, M.
Peregrine, A.S.
author_browse Murphy, N.B.
Muthiani, M.
Peregrine, A.S.
author_facet Murphy, N.B.
Muthiani, M.
Peregrine, A.S.
author_sort Murphy, N.B.
collection Repository of Agricultural Research Outputs (CGSpace)
description We determined the level of susceptibility of Trypanosoma brucei brucei to the aminoglycoside G418 in vivo and demonstrated that it is possible to select for G418-resistant transfected T. brucei brucei bloodstream parasites in a mouse host by inoculating the drug intraperitoneally at doses between 40 and 80 mg/kg of body weight daily for 3 days. The ability to select for transfectants in vivo offers new possibilities for studies on genetic recombination in these parasites.
format Journal Article
id CGSpace30080
institution CGIAR Consortium
language Inglés
publishDate 1993
publishDateRange 1993
publishDateSort 1993
publisher American Society for Microbiology
publisherStr American Society for Microbiology
record_format dspace
spelling CGSpace300802024-05-01T08:15:54Z Use of an in vivo system to determine the G418 resistance phenotype of bloodstream-form Trypanosoma brucei brucei transfectants Murphy, N.B. Muthiani, M. Peregrine, A.S. trypanosoma brucei infectious diseases pharmacology We determined the level of susceptibility of Trypanosoma brucei brucei to the aminoglycoside G418 in vivo and demonstrated that it is possible to select for G418-resistant transfected T. brucei brucei bloodstream parasites in a mouse host by inoculating the drug intraperitoneally at doses between 40 and 80 mg/kg of body weight daily for 3 days. The ability to select for transfectants in vivo offers new possibilities for studies on genetic recombination in these parasites. 1993-05 2013-06-11T09:26:08Z 2013-06-11T09:26:08Z Journal Article https://hdl.handle.net/10568/30080 en Open Access American Society for Microbiology Antimicrobial Agents and Chemotherapy;37: 1167-1170
spellingShingle trypanosoma brucei
infectious diseases
pharmacology
Murphy, N.B.
Muthiani, M.
Peregrine, A.S.
Use of an in vivo system to determine the G418 resistance phenotype of bloodstream-form Trypanosoma brucei brucei transfectants
title Use of an in vivo system to determine the G418 resistance phenotype of bloodstream-form Trypanosoma brucei brucei transfectants
title_full Use of an in vivo system to determine the G418 resistance phenotype of bloodstream-form Trypanosoma brucei brucei transfectants
title_fullStr Use of an in vivo system to determine the G418 resistance phenotype of bloodstream-form Trypanosoma brucei brucei transfectants
title_full_unstemmed Use of an in vivo system to determine the G418 resistance phenotype of bloodstream-form Trypanosoma brucei brucei transfectants
title_short Use of an in vivo system to determine the G418 resistance phenotype of bloodstream-form Trypanosoma brucei brucei transfectants
title_sort use of an in vivo system to determine the g418 resistance phenotype of bloodstream form trypanosoma brucei brucei transfectants
topic trypanosoma brucei
infectious diseases
pharmacology
url https://hdl.handle.net/10568/30080
work_keys_str_mv AT murphynb useofaninvivosystemtodeterminetheg418resistancephenotypeofbloodstreamformtrypanosomabruceibruceitransfectants
AT muthianim useofaninvivosystemtodeterminetheg418resistancephenotypeofbloodstreamformtrypanosomabruceibruceitransfectants
AT peregrineas useofaninvivosystemtodeterminetheg418resistancephenotypeofbloodstreamformtrypanosomabruceibruceitransfectants